Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Faecal Microbiota Transplantation to Eradicate Gut Colonisation From CRE
NCT04759001Phase 2Recruiting
- Sponsor
- Policlinico Gemelli
- Start
- Feb 2021
- Primary completion
- Mar 2026
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Enterobacteriaceae colonization comparing Donor FMT with Placebo FMT (2 arms). Primary endpoint: Number of participants who will obtain an eradication of CRE carriage after treatments at 4 weeks. Started Feb 2021; status: recruiting.
02
Drugs
allogeneic fecal microbiota
03
Conditions
Enterobacteriaceae colonization
Beyond the preview
Go deeper on NCT04759001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04759001.